We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

A Double-Blind, Randomized, Parallel, Comparative Study to Evaluate the Efficacy and Safety of an Antidiabetic Agent Repaglinide for the Treatment of Type 2 Diabetes Mellitus Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00336310
Recruitment Status : Unknown
Verified June 2006 by National Cheng-Kung University Hospital.
Recruitment status was:  Not yet recruiting
First Posted : June 13, 2006
Last Update Posted : June 13, 2006
Information provided by:
National Cheng-Kung University Hospital

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Unknown
  Primary Completion Date : No date given
  Study Completion Date : No date given